RU2018137897A - Пути улучшения лечения рака - Google Patents
Пути улучшения лечения рака Download PDFInfo
- Publication number
- RU2018137897A RU2018137897A RU2018137897A RU2018137897A RU2018137897A RU 2018137897 A RU2018137897 A RU 2018137897A RU 2018137897 A RU2018137897 A RU 2018137897A RU 2018137897 A RU2018137897 A RU 2018137897A RU 2018137897 A RU2018137897 A RU 2018137897A
- Authority
- RU
- Russia
- Prior art keywords
- weight
- composition
- amount
- suppository
- compound
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title claims 4
- 201000011510 cancer Diseases 0.000 title claims 4
- 239000000203 mixture Substances 0.000 claims 24
- 150000001875 compounds Chemical class 0.000 claims 10
- 235000019197 fats Nutrition 0.000 claims 8
- 239000000829 suppository Substances 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 4
- 238000002512 chemotherapy Methods 0.000 claims 3
- 238000001959 radiotherapy Methods 0.000 claims 3
- 239000006216 vaginal suppository Substances 0.000 claims 3
- 229940120293 vaginal suppository Drugs 0.000 claims 3
- AOHAPDDBNAPPIN-UHFFFAOYSA-N 3-Methoxy-4,5-methylenedioxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC2=C1OCO2 AOHAPDDBNAPPIN-UHFFFAOYSA-N 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 2
- 239000005639 Lauric acid Substances 0.000 claims 1
- 235000021314 Palmitic acid Nutrition 0.000 claims 1
- 235000021355 Stearic acid Nutrition 0.000 claims 1
- 229940110456 cocoa butter Drugs 0.000 claims 1
- 235000019868 cocoa butter Nutrition 0.000 claims 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 235000003441 saturated fatty acids Nutrition 0.000 claims 1
- 150000004671 saturated fatty acids Chemical class 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 claims 1
- 239000008117 stearic acid Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662318946P | 2016-04-06 | 2016-04-06 | |
| US62/318,946 | 2016-04-06 | ||
| PCT/AU2016/050674 WO2017173474A1 (en) | 2016-04-06 | 2016-07-28 | Improvements in cancer treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2018137897A3 RU2018137897A3 (enExample) | 2020-05-13 |
| RU2018137897A true RU2018137897A (ru) | 2020-05-13 |
Family
ID=60000141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018137897A RU2018137897A (ru) | 2016-04-06 | 2016-07-28 | Пути улучшения лечения рака |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20190160004A1 (enExample) |
| EP (2) | EP3939583A1 (enExample) |
| JP (1) | JP2019510830A (enExample) |
| KR (1) | KR20190016017A (enExample) |
| CN (1) | CN109475522A (enExample) |
| AU (2) | AU2016401508B2 (enExample) |
| CA (1) | CA3058479A1 (enExample) |
| IL (1) | IL262143A (enExample) |
| RU (1) | RU2018137897A (enExample) |
| SG (1) | SG11201808777UA (enExample) |
| WO (1) | WO2017173474A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019513826A (ja) * | 2016-04-06 | 2019-05-30 | ノクソファーム リミティド | 放射線療法の改善 |
| CA3058503A1 (en) | 2016-04-06 | 2017-10-12 | Noxopharm Limited | Isoflavonoid composition with improved pharmacokinetics |
| JP2023519990A (ja) | 2020-03-30 | 2023-05-15 | ノクソファーム リミティド | 感染に関連する炎症の治療のための方法 |
| WO2022204757A1 (en) * | 2021-03-30 | 2022-10-06 | Noxopharm Limited | Improved isoflavone formulation |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO203996A0 (en) * | 1996-08-30 | 1996-09-26 | Novogen Research Pty Ltd | Therapeutic uses |
| US8178123B2 (en) * | 2001-08-29 | 2012-05-15 | Femina Pharma Incorporated | Method for augmentation of intraepithelial and systemic exposure of therapeutic agents having substrate activity for cytochrome P450 enzymes and membrane efflux systems following vaginal and oral cavity administration |
| CN1681386B (zh) * | 2002-07-24 | 2010-05-26 | 儿童医院医疗中心 | 含有对映体牛尿酚的组合物和产物及其制备方法 |
| AU2002951833A0 (en) * | 2002-10-02 | 2002-10-24 | Novogen Research Pty Ltd | Compositions and therapeutic methods invloving platinum complexes |
| JP2007525485A (ja) | 2003-11-19 | 2007-09-06 | ノボゲン リサーチ ピーティーワイ リミテッド | 複合的な放射線治療及び化学治療の組成物及び方法 |
| DE102005009515A1 (de) * | 2005-02-25 | 2006-09-07 | Exner, Heinrich, Dr. | Verfahren zur Herstellung einer Zubereitung einer DMSO-haltigen festen Silikonölemulsion zur Bindung von reaktiven Sauerstoffverbindungen im Körper von Menschen und Tieren |
| EP1948103A2 (en) * | 2005-09-15 | 2008-07-30 | UMD, Inc. | A method of intraepithelial and systemic exposure of therapeutic agents following vaginal and oral cavity administration |
| US20110166142A1 (en) * | 2007-06-29 | 2011-07-07 | Eleanor Eiffe | 2-substituted isoflavonoid compounds, medicaments and uses |
| EP2334296A4 (en) * | 2008-08-29 | 2012-04-25 | Novogen Res Pty Ltd | IMMUNOMODULATING ACTIVITIES |
| KR20110004525A (ko) * | 2009-07-08 | 2011-01-14 | 동의대학교 산학협력단 | 제니스테인과 ｔｒａｉｌ을 포함하는 간암 치료용 조성물 |
-
2016
- 2016-07-28 CN CN201680086470.1A patent/CN109475522A/zh active Pending
- 2016-07-28 AU AU2016401508A patent/AU2016401508B2/en not_active Ceased
- 2016-07-28 EP EP21176052.5A patent/EP3939583A1/en not_active Withdrawn
- 2016-07-28 SG SG11201808777UA patent/SG11201808777UA/en unknown
- 2016-07-28 US US16/091,688 patent/US20190160004A1/en not_active Abandoned
- 2016-07-28 WO PCT/AU2016/050674 patent/WO2017173474A1/en not_active Ceased
- 2016-07-28 JP JP2019503595A patent/JP2019510830A/ja active Pending
- 2016-07-28 KR KR1020187032107A patent/KR20190016017A/ko not_active Withdrawn
- 2016-07-28 CA CA3058479A patent/CA3058479A1/en not_active Abandoned
- 2016-07-28 EP EP16897482.2A patent/EP3439651A4/en not_active Withdrawn
- 2016-07-28 RU RU2018137897A patent/RU2018137897A/ru not_active Application Discontinuation
-
2018
- 2018-10-04 IL IL262143A patent/IL262143A/en unknown
-
2020
- 2020-06-23 AU AU2020204172A patent/AU2020204172A1/en not_active Abandoned
-
2021
- 2021-05-24 US US17/328,041 patent/US20210338576A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| RU2018137897A3 (enExample) | 2020-05-13 |
| EP3439651A4 (en) | 2019-10-30 |
| IL262143A (en) | 2018-11-29 |
| SG11201808777UA (en) | 2018-11-29 |
| AU2020204172A1 (en) | 2020-07-09 |
| WO2017173474A1 (en) | 2017-10-12 |
| EP3939583A1 (en) | 2022-01-19 |
| CN109475522A (zh) | 2019-03-15 |
| KR20190016017A (ko) | 2019-02-15 |
| AU2016401508A1 (en) | 2018-11-01 |
| AU2016401508B2 (en) | 2020-03-26 |
| JP2019510830A (ja) | 2019-04-18 |
| EP3439651A1 (en) | 2019-02-13 |
| CA3058479A1 (en) | 2017-10-12 |
| US20190160004A1 (en) | 2019-05-30 |
| US20210338576A1 (en) | 2021-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2018137897A (ru) | Пути улучшения лечения рака | |
| RU2018138828A (ru) | Уменьшение массы опухоли путем введения ccr1 антагонистов в комбинации с pd-1 ингибиторами или pd-l1 ингибиторами | |
| EA202190471A1 (ru) | Комбинация конъюгата антитела-лекарственного средства и ингибитора тубулина | |
| RU2012118974A (ru) | Комбинации ингибитора pi3k и ингибитора мек | |
| RU2012145116A (ru) | Фармацевтическая композиция для предупреждения или лечения неалкогольного жирового гепатоза и способ предупреждения или лечения неалкогольного жирового гепатоза с ее использованием | |
| CA2263203A1 (en) | 3,6-ketal and enol ether macrolide antibiotics | |
| RU2006117339A (ru) | Применение антибиотиков в качестве адъювантов вакцин | |
| MX389965B (es) | Compuestos de pirrolopiridina-anilina para el tratamiento de trastornos dermicos | |
| CA3015494C (en) | Novel compositions and therapeutic methods | |
| WO2020097127A3 (en) | B-cell activating cd73 antibodies | |
| RU2012114189A (ru) | Фармацевтические композиции для лечения грибковых инфекций | |
| RU2018101431A (ru) | Ингибиторы индоламин-2,3-диоксигеназы | |
| PH12019500618A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
| JOP20190209A1 (ar) | مركبات إيميدازو [ 4، 5-c ] كينولين-2-أون ديوترومية واستخدامها في علاج السرطان | |
| RU2012150501A (ru) | Противораковые стероидные лактоны, ненасыщенные в положении 7(8) | |
| RU2003134629A (ru) | Соединения цефема | |
| RU2018103753A (ru) | Ингибиторы гистондеацетилазы | |
| RU2009128970A (ru) | Производные изосорбидмононитрата для лечения кишечных заболеваний | |
| JP2019510830A5 (enExample) | ||
| RU2007138582A (ru) | Пероральные дозированные формы производных гемцитабина | |
| KR910018383A (ko) | 종양성 질환 치료용 엽산염 및 항엽산염과의 디플루오로글루 탐산 공역체 | |
| EA201891744A1 (ru) | ГЛЮКОНО-δ-ЛАКТОН ДЛЯ ЛЕЧЕНИЯ ВАГИНАЛЬНЫХ ГРИБКОВЫХ ИНФЕКЦИЙ | |
| KR940013500A (ko) | 수생 종의 그람-양성 질환 치료방법 | |
| RU2522449C1 (ru) | Средство, обладающее антипролиферативным и антиметастатическим действием, для лечения опухолевых заболеваний | |
| RU2019101849A (ru) | Композиции и способы лечения синдрома раздраженного кишечника |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20220111 |